Results 121 to 130 of about 343,983 (293)

Medicinal Use of Cannabis in Canines

open access: yes, 2023
Medicinal cannabis continues to gain popularity for treating a variety of health issues for both humans and animals. This paper examines this growing trend and looks closer at the benefits canine cannabis offers in veterinary care.
Kimbriel, Tailor   +2 more
core  

Unraveling Suicidal Ideation and Behaviors in a Global Cohort of Individuals at Clinical High‐Risk for Psychosis: Multivariable Correlates and Subthreshold Psychotic Symptoms

open access: yesActa Psychiatrica Scandinavica, EarlyView.
ABSTRACT Introduction Suicidal ideation and behaviors (SIB) are common among individuals at clinical high risk for psychosis (CHR‐P), but their relationship with the overall clinical profile remains unclear. This study aimed to identify sociodemographic/clinical factors associated with SIB in CHR‐P individuals and to examine whether subthreshold ...
Stefano Damiani   +73 more
wiley   +1 more source

National economic opening of the medicinal use of cannabis and export of its derivatives

open access: yes, 2022
Hablar de la legalización, el uso controlado y regulado del cannabis medicinal en Colombia hace varias décadas atrás era impensable, todo el impacto socioeconómico que ha trascendido por muchos años en el país lo cual conllevo a violencia desenfrenada y ...
Salcedo Sierra, Huver Yesid
core   +1 more source

Psychedelic‐assisted treatment for substance use disorder: A narrative systematic review

open access: yesAddiction, EarlyView.
Abstract Background and aims This is the first systematic review of the extant literature on all major psychedelic‐assisted treatment for alcohol use disorder (AUD), tobacco use disorder (TUD) and other substance use disorders (SUD). We aimed to summarise the evidence for efficacy of psychedelic‐assisted treatment for AUD, TUD, and SUD; to evaluate its
Theodore Piper   +7 more
wiley   +1 more source

Ireland ‘sleepwalking’ into liberal cannabis regime, warn doctors.

open access: yes, 2019
Campaigners say medicinal cannabis being used as ‘Trojan horse’ towards legalisation.....
Cullen, Paul
core  

Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial

open access: yesAddiction, EarlyView.
Abstract Background and Aims Psilocybin has emerged as a potential treatment for alcohol use disorder (AUD), but early efficacy data are inconsistent. Depression following alcohol detoxification significantly increases the risk of relapse. This pilot study aimed to evaluate the feasibility, acceptability, and preliminary efficacy of psilocybin‐assisted
Amandine Luquiens   +7 more
wiley   +1 more source

Envisaging challenges for the emerging medicinal Cannabis sector in Lesotho

open access: yesJournal of Cannabis Research
Background Cultivation of Cannabis and its use for medical purposes has existed for millennia on the African continent. The plant has also been widely consumed in the African continent since time immemorial.
Regina M. Thetsane
doaj   +1 more source

Comparative Study on the Protection of the Right to Health through the Regulation of Cannabis Use in Indonesia and Thailand

open access: yesLaw Research Review Quarterly
Cannabis is a plant that has medicinal benefits. However, the use of cannabis is prohibited by Indonesian Law Number 35 of 2009 concerning Narcotics, which states that cannabis is a Class I narcotic and cannot be used for medical purposes.
Firdaus Mario Nathanael, Ratih Damayanti
doaj   +1 more source

Psilocybin‐assisted psychotherapy for methamphetamine use disorder: A pilot open‐label safety and feasibility study

open access: yesAddiction, EarlyView.
Abstract Background & Aims There are few effective treatments for methamphetamine use disorder, despite increasing global demand. Here, we assessed the safety and feasibility of outpatient psilocybin‐assisted psychotherapy for methamphetamine use disorder. Design Single arm, open label pilot study.
Elizabeth Knock   +8 more
wiley   +1 more source

Estimating thresholds for risk of cannabis use disorder using standard delta‐9‐tetrahydrocannabinol (THC) units

open access: yesAddiction, EarlyView.
Abstract Background and aims Lower risk guidelines for safer levels of cannabis use could help to reduce the health burden posed by cannabis use disorder (CUD). We aimed to estimate risk thresholds for CUD based on delta‐9‐tetrahydrocannabinol (THC) consumption using standard THC units (1 unit = 5 mg THC).
Rachel Lees Thorne   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy